Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929
| Autor: | Abdel Karim, Nagla, Miao, Jieling, Reckamp, Karen L., Gay, Carl M., Byers, Lauren A., Zhao, Ying-Qi, Redman, Mary W., Carrizosa, Daniel R., Wang, Wei-Lien, Petty, William J., Mehta, Kathan, Faller, Bryan A., Agamah, Edem S., Kasbari, Samer S., Malisetti, Rajini K., Kumar, Atul, Schallenkamp, John, Alluri, Krishna C., Gray, Jhanelle E., Kelly, Karen |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|